3 Reasons To Buy Carillion plc Instead Of Balfour Beatty plc

Roland Head explains why Carillion plc (LON:CLLN) is an attractive buy, but Balfour Beatty plc (LON:BBY) remains too risky.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Richard Howson, the chief executive of infrastructure and support services group Carillion (LSE: CLLN), must be smiling today.

It’s nearly a year after the firm’s failed attempt to merge with Balfour Beatty (LSE: BBY), and it seems pretty certain that Carillion had a lucky escape.

Since the failed negotiations last year, Balfour has stumbled from one problem to the next.

In contrast, Carillion has made steady progress with its strategy of focusing on controlling costs and targeting high-quality projects.

In a trading statement released on Tuesday, Carillion reported that profits and earnings were expected to be in line with expectations this year, and said that there had been a “significant increase in first-half revenue”.

Carillion also took the opportunity to announce an £80m contract to build an operational and accommodation complex for BP in Oman, which is expected to start in September and complete in mid-2017.

More losses for Balfour

In contrast, Balfour’s most recent update, issued on 9 July, revealed that the company has identified yet more problems with existing contracts. These are expected to result in pre-tax profits being between £120m and £150m lower than expected this year.

The firm’s only profitable and healthy business, the Parsons Brinckerhoff consultancy, was sold in October 2014. While the cash helped to strengthen Balfour’s balance sheet, I suspect this sale may seem short-sighted in years to come.

Of course, it’s possible that Balfour will prove to be a successful contrarian buy, outperforming Carillion over the next year.

It’s possible, but I’m not convinced. Here are three reasons why I’d be inclined to sell Balfour and buy Carillion at today’s prices.

1. Value

Balfour looks too expensive. In my view the current share price already factors in a successful recovery.

Balfour currently trades on a 2015 forecast P/E of 25, falling to a P/E of 15.3 for 2016. In contrast, Carillion trades on a forecast P/E of 10.4 for 2015, falling to 10.0 in 2016.

Although this implies that Carillion’s growth is likely to be limited next year, I’d rather take this risk than expose my money to Balfour’s toxic cauldron of loss-making contracts.

2. Income

Growth may be plodding at Carillion, but the firm’s shares offer a well-covered 5.2% dividend yield.

Carillion’s dividend has risen every year since 1999, climbing by 344% from 4p per share, to last year’s level of 17.7p per share.

In contrast, Balfour’s dividend was cut by 60% from 14.1p to just 5.6p in 2014. A further 45% cut to 3.1p is forecast by analysts for 2015. Balfour also cut its payout in both 1999 and 2000.

Carillion’s slow and steady approach may be boring, but it has been very profitable for long-term shareholders.

3. Profitability

Even during the good times, Balfour Beatty’s operating margin didn’t make it much higher than 3%. As we’ve seen over the last two years, this leaves precious little room for errors or unexpected problems.

In contrast, Carillion’s mix of infrastructure and support services is more profitable. The firm’s operating margin has average 4.3% since 2009 and was 5.4% in 2014.

It’s a simple choice

For me, it’s there’s no contest. I’d be happy to put my money into Carillion’s well-run and stable business, but will continue to avoid Balfour Beatty.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Roland Head has no position in any shares mentioned. The Motley Fool UK has no position in any of the shares mentioned. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

Despite rising 152% in a year, is Rolls-Royce’s share price still a bargain?

While Rolls-Royce’s share price has shot up recently, it still looks very undervalued against its peers, and the business looks…

Read more »

Investing Articles

Could Nvidia stock be a bargain in plain sight?

Nvidia stock has surged 252% over the past 12 months, but that doesn't mean it's expensive. In fact, it may…

Read more »

Investing Articles

Here’s why I think the Vodafone share price should be 110% higher

Reflecting on speculation, our writer believes there’s a case to be made for the Vodafone share price being more than…

Read more »

A pastel colored growing graph with rising rocket.
Investing Articles

Is this dividend star also the best bargain in the FTSE 100?

This FTSE 100 stock pays a whopping 8%+ yield, looks very undervalued against its peers, and is set for stellar…

Read more »

Investing Articles

2 FTSE 100 stocks. One sublime, the other ridiculous

Our writer doesn’t understand the appeal of Ocado. But looking at the grocer’s latest results makes him see the attraction…

Read more »

Portrait of elderly man wearing white denim shirt and glasses looking up with hand on chin. Thoughtful senior entrepreneur, studio shot against grey background.
Investing Articles

Down 18% in a year, what’s next for the Greatland Gold (GGP) share price?

The Greatland Gold share price has disappointed over the past 12 months. Our writer asks whether the company’s latest update…

Read more »

Investor looking at stock graph on a tablet with their finger hovering over the Buy button
Investing Articles

With 30% annual returns for a decade, I’m buying this for my Stocks & Shares ISA

Oliver Rodzianko has been looking for a new investment for his Stocks and Shares ISA. Here's one he's decided is…

Read more »

Investing Articles

These were the FTSE 100’s dogs and stars in February

The FTSE 100 limped along last month, but some Footsie shares soared while others slumped. Here are February's winners and…

Read more »